Gritstone Bio Inc (GRTS)
0.8647
-0.01
(-0.61%)
USD |
NASDAQ |
May 02, 12:53
Gritstone Bio 1 Year Total Returns (Daily): -64.34% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | -64.34% |
April 30, 2024 | -66.39% |
April 29, 2024 | -66.13% |
April 26, 2024 | -65.82% |
April 25, 2024 | -68.41% |
April 24, 2024 | -68.49% |
April 23, 2024 | -72.13% |
April 22, 2024 | -71.87% |
April 19, 2024 | -72.20% |
April 18, 2024 | -71.72% |
April 17, 2024 | -73.85% |
April 16, 2024 | -74.52% |
April 15, 2024 | -75.61% |
April 12, 2024 | -69.96% |
April 11, 2024 | -69.47% |
April 10, 2024 | -66.68% |
April 09, 2024 | -64.67% |
April 08, 2024 | -63.54% |
April 05, 2024 | -61.19% |
April 04, 2024 | -59.09% |
April 03, 2024 | -56.88% |
April 02, 2024 | -56.83% |
April 01, 2024 | -15.47% |
March 28, 2024 | 3.63% |
March 27, 2024 | 12.90% |
Date | Value |
---|---|
March 26, 2024 | 4.86% |
March 25, 2024 | 8.91% |
March 22, 2024 | 10.48% |
March 21, 2024 | 6.04% |
March 20, 2024 | 11.89% |
March 19, 2024 | 8.84% |
March 18, 2024 | -0.80% |
March 15, 2024 | -6.67% |
March 14, 2024 | -13.51% |
March 13, 2024 | 4.42% |
March 12, 2024 | 17.84% |
March 11, 2024 | 13.15% |
March 08, 2024 | 11.34% |
March 07, 2024 | 10.68% |
March 06, 2024 | -12.10% |
March 05, 2024 | -20.00% |
March 04, 2024 | -16.47% |
March 01, 2024 | -15.48% |
February 29, 2024 | 14.29% |
February 28, 2024 | 15.92% |
February 27, 2024 | 12.35% |
February 26, 2024 | 1.24% |
February 23, 2024 | -12.60% |
February 22, 2024 | -17.86% |
February 21, 2024 | -19.69% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-81.00%
Minimum
Jan 24 2022
343.7%
Maximum
Dec 17 2021
-7.44%
Average
-42.91%
Median
Mar 25 2020
1 Year Total Returns (Daily) Benchmarks
Precision BioSciences Inc | -59.02% |
Humacyte Inc | 31.04% |
Verastem Inc | 89.02% |
BioVie Inc | -93.73% |
Syros Pharmaceuticals Inc | 67.90% |